{
    "clinical_study": {
        "@rank": "149719", 
        "arm_group": [
            {
                "arm_group_label": "non-urate calculus"
            }, 
            {
                "arm_group_label": "non-calculus"
            }, 
            {
                "arm_group_label": "urate calculus"
            }
        ], 
        "brief_summary": {
            "textblock": "This study intends to use in patients with renal tissue and blood samples, screening and\n      identification of renal tissue hURAT1 regulating the expression of micro-RNA, for further\n      study of uric acid stone formation mechanism and the occurrence of clinical preventive uric\n      acid stones provide new clues and new intervention targets."
        }, 
        "brief_title": "Screening and Identification of Human Urate Transporter hURAT1 MicroRNA", 
        "condition": "Urinary Calculi", 
        "condition_browse": {
            "mesh_term": [
                "Calculi", 
                "Urinary Calculi"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        A\u3001B group were enrolled standards: \u2460 aged 18-65 years old; \u2461 comply with percutaneous\n        nephrolithotomy lithotripsy indications for surgery; \u2462 ECT tips ipsilateral normal or\n        mildly impaired renal function.\n\n        Group C patients were enrolled standards: \u2460 aged 18-65 years old; \u2461 normal renal function,\n        not associated with urinary calculi in patients; \u2462 cancer patients met radical nephrectomy\n        indications for surgery; \u2463 emergency trauma patients suffering from kidney resection\n        surgical indications.\n\n        Exclusion Criteria:\n\n          -  aged <18 years or> 65 years; \u2461 neurological disease or cognitive dysfunction; \u2462 can\n             not be corrected or uncorrected coagulopathy; \u2463 associated with diabetes,\n             hypertension and other metabolic diseases; \u2464 accompanied by tuberculosis, hepatitis,\n             HIV and other infectious diseases; \u2465 poor tolerance to anesthesia and surgery, such\n             as: severe cardiopulmonary disease, coagulation disorders, etc.; \u2466 ultrasound, renal\n             imaging examination revealed renal cortex was significantly thinner (renal cortical\n             thickness <1.5cm), structural variation; \u2467 with severe systemic or urinary tract\n             infection; \u2468 ECT tips ipsilateral renal function is severely impaired or solitary\n             kidney."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Experiment are divided into uric acid stones group (A), non-uric acid stones group (B),\n        control group (C), A, C recruited 30 patients each group, B group recruited 20 patients."
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01973088", 
            "org_study_id": "Southwest Hospital,TMMU"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 8, 2013", 
        "number_of_groups": "3", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "microRNA microarray:the micro-RNA of kidney tissue", 
            "measure": "micro-RNA", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01973088"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Southwest Hospital, China", 
            "investigator_full_name": "Qian-wei Li", 
            "investigator_title": "Southwest Hospital, China", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Urine Analyzer:Urine color, transparency, pH, erythrocytes, leukocytes, epithelial cells, casts, protein, specific gravity, and qualitative urine", 
                "measure": "Urine", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Urine Analyzer:Urine, sodium, potassium, calcium, magnesium, ammonium, phosphate, sulfate, uric acid, oxalate, citrate, creatinine", 
                "measure": "24h urine quantitative analysis", 
                "safety_issue": "No", 
                "time_frame": "96 hours"
            }, 
            {
                "description": "Blood biochemical analyzer:Sodium, potassium, chloride, calcium, phosphorus, magnesium, bicarbonate, uric acid, creatinine", 
                "measure": "Blood biochemistry", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Infrared Spectroscopy:Calcium oxalate monohydrate , carbonated apatite, calcium oxalate dihydrate ,anhydrous uric acid, urine ammonium,magnesium ammonium phosphate", 
                "measure": "Stone analysis", 
                "safety_issue": "No", 
                "time_frame": "3 weeks"
            }, 
            {
                "description": "WESTERN BLOT\u3001RT-qPCR:hURAT1 transporter protein of kidney tissue", 
                "measure": "hURAT1 transporter protein", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Southwest Hospital, China", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Qian-wei Li", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}